0000950123-20-009708 Sample Contracts

LEASE BETWEEN DISCOVERY BUSINESS CENTER LLC AND TARSUS PHARMACEUTICALS, INC.

Lease • September 14th, 2020 • Tarsus Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California

• Contract Type
  Lease
• Filed
  September 14th, 2020
• Company
  Tarsus Pharmaceuticals, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

THIS LEASE is made as of May 28, 2020, by and between DISCOVERY BUSINESS CENTER LLC, a Delaware limited liability company, hereafter called “Landlord,” and TARSUS PHARMACEUTICALS, INC., a Delaware corporation, hereafter called “Tenant.”

LICENSE AGREEMENT

License Agreement • September 14th, 2020 • Tarsus Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  License Agreement
• Filed
  September 14th, 2020
• Company
  Tarsus Pharmaceuticals, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

THIS LICENSE AGREEMENT (the “Agreement”), dated as of September 3, 2020 (the “Effective Date”), is made and entered into by and between Elanco Tiergesundheit AG, a Swiss corporation having place of business at Mattenstrasse 24A, 4058 Basel, Switzerland (“Elanco”) and Tarsus Pharmaceuticals, Inc., a Delaware corporation having its principal offices at 4590 MacArthur Blvd. Suite 500, Newport Beach, CA 92660 (“Tarsus”). Each of Elanco and Tarsus may be referred to herein as a “Party” and collectively as the “Parties.”

SUBLEASE AGREEMENT

Sublease Agreement • September 14th, 2020 • Tarsus Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)

• Contract Type
  Sublease Agreement
• Filed
  September 14th, 2020
• Company
  Tarsus Pharmaceuticals, Inc.
• Industry
  Biological products, (no disgnostic substances)

THIS SUBLEASE AGREEMENT (“Sublease”) is made and entered into this 29th day of May, 2020 by and between AVENT, INC., a Delaware corporation (hereinafter “Sublessor”) and TARSUS PHARMACEUTICALS, INC., a Delaware corporation (hereinafter “Sublessee”).

AMENDMENT TO LICENSE AGREEMENT

License Agreement • September 14th, 2020 • Tarsus Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)

• Contract Type
  License Agreement
• Filed
  September 14th, 2020
• Company
  Tarsus Pharmaceuticals, Inc.
• Industry
  Biological products, (no disgnostic substances)

This Amendment to License Agreement (“Amendment”) is made and entered into as of September 3, 2020 (the “Amendment Effective Date”) by and between Elanco Tiergesundheit AG, a Swiss corporation having place of business at Mattenstrasse 24A, 4058 Basel, Switzerland (“Elanco”) and Tarsus Pharmaceuticals, Inc., a Delaware corporation having its principal offices at 4590 MacArthur Blvd. Suite 500, Newport Beach, CA 92660 (“Tarsus”).